As of May 03, 2025, Pliant Therapeutics (PLRX) has a market cap of $90.852 million USD. According to our data, Pliant Therapeutics is ranked No.7692 in global market value.
Year | Market Cap | %Change |
---|---|---|
May 03, 2025 | $90.85 M |
-88.66%
|
Dec 31, 2024 | $0.80 B |
-27.28%
|
Dec 29, 2023 | $1.10 B |
-6.31%
|
Dec 30, 2022 | $1.18 B |
43.19%
|
Dec 31, 2021 | $0.82 B |
-40.58%
|
Dec 31, 2020 | $1.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() FibroGen
FGEN
|
$33.05 M |
0.000 M
|
![]() USA
|
![]() Galapagos NV
GLPG
|
$1.77 B |
0.000 M
|
![]() Belgium
|
![]() Genfit
GNFT
|
$0.20 B |
2.557 M
|
![]() France
|
![]() Morphic Therapeutic
MORF
|
$2.86 B |
0.000 M
|
![]() USA
|
![]() Akero Therapeutics
AKRO
|
$3.43 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
Market Cap | = | PLRX Stock Price | * | PLRX Shares Outstanding |
= | $1.48 | * | 61.39 M | |
= | $90.85 M |